Ask where the pharmaceutical market deepening.docVIP

 PAGE \* MERGEFORMAT 10 Ask where the pharmaceutical market deepening Record offer: Li-Wei Zhang (Beijing, general manager of a marketing management consulting firm [Complaints] B Company is a small pharmaceutical company, its products mainly rely on the national investment and some generic drugs to sell in the circulation market, with annual sales of about 3,500 million, of which 40% of total sales of generic drugs, accounting for 60% of the investment part of the main nearly 20 kinds of products, relying on the regional market agents in the clinical, OTC sales channels such as the back section. How to get four legs After several years of development, the initial set up complete sales network, the major markets in the provinces have cooperated with customers, but due to weak product, health care and other hardware is not strong bid, competition and other factors, starting in 2005 , corporate sales growth. To this end, managers deepen the market early last year on the agenda, and development of relevant targets, to determine the “deepening of the market, multi-legged walking,” the general direction of the market in an attempt to consolidate the basis for a comprehensive , out of sales of the “bottleneck.” The company’s specific objectives and measures include the following four aspects. 1. Chain of pharmacies, and the third terminal, clinical full bloom, do everything possible to develop a variety of products of various sales channels, to build a comprehensive network of channels, multi-legged walking, Guangzhou and Shenzhen both to raise the overall sales and market influence. 2. Chain pharmacies: National Pharmacy hundred lock list in 2007, positive and contact one of the large chain pharmacies cooperation can co-chain of a certain amount of credit terminals, cash cycle control in 3 months. 3. The third terminal: in C, H, S and other places to set up offices, recruitment of personnel to operate the third terminal, with local resources to oper